Comparative Efficacy and Safety Among Sodium-glucose Cotransporter-2 Inhibitors in Type 2 Diabetes – Results from a Retrospective Single-centre Study

Introduction: This retrospective analysis compared the real-world effectiveness and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus in India. Methods: All patients initiated on canagliflozin (C; 100 mg), dapagliflozin (D; 10 mg) and empagliflozi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baruah, Manash P, Kalra, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2019
Materias:
Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785952/
https://www.ncbi.nlm.nih.gov/pubmed/31616503
http://dx.doi.org/10.17925/EE.2019.15.2.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785952/
https://www.ncbi.nlm.nih.gov/pubmed/31616503
http://dx.doi.org/10.17925/EE.2019.15.2.113

Ejemplares similares